Comparing Minisling to Tension Free Vaginal Tape in Mangement of Stress Urinary Incontinence

September 18, 2018 updated by: Ahmed Reda, Ain Shams University

Randomized Controlled Trial Comparing Minisling to Tension Free Vaginal Tape in Mangement of Stress Urinary Incontinence

Based on previous studies the single incision minisling is an easy less invasive procedure with fewer complications and cure rate similar to conventional midurethral slings in the treatment of female stress urinary incontinence. The aim of this study is to test the hypothesis that the single incision mini-sling placed in the "U" position is not inferior to TVT in this patient population.

Study Overview

Study Type

Interventional

Enrollment (Actual)

48

Phase

  • Phase 2
  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt
        • Ain Shams University, Maternity Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Patients with urodynamic stress urinary incontinence, with or without pelvic organ prolapse

Exclusion Criteria:

  • Patients with overactive bladder on urodynamic study.
  • Patients with voiding dysfunction.
  • Patients with intrinsic sphincteric deficiency.
  • Patients with previous anti-incontinence surgery.
  • Patients on anti-coagulant therapy.
  • Immune-compromised patients (DM, patients on corticosteroids treatment).
  • Refusal of surgery.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: minisling
patients in this arm will undergo single incision minisling
midline incision of the vagina at midurethral level dissection of the vagina from perivesical fascia insertion of the tape (polypropylene macropore mesh tape) in the retropubic direction with its end grasped with an artery forceps till level of perineal membrane closure of the vagina 2 sham incisions if the skin only will be made at suprapubic to maintain blindness posterior colpoperneorraphy will be carried out if needed
Sham Comparator: tension free vaginal tape
patients in this arm will undergo tension free vaginal tape
midline incision of the vagina at midurethral level dissection of the vagina from perivesical fascia insertion of the tape (polypropylene macropore mesh tape) with the applicators in the retropubic direction and 2 skin incision will be made supra pubic through which the applicators will be passed and removed and the tape will be cut at level just below the skin closure of the vagina posterior colpoperneorraphy will be carried out if needed
Other Names:
  • TVT

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
objective cure rate of urinary incontinence at 12 months after surgery
Time Frame: 12 months
Objective cure is indicated by a negative stress test and the absence of any additional surgical or nonsurgical treatment for stress urinary incontinence
12 months
subjective cure rate of urinary incontinence at 12 months after surgery
Time Frame: 12 months
subjective cure is indicated by an Incontinence Severity Index score of 0 and the absence of any additional surgical or nonsurgical treatment for stress urinary incontinence
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants with short- term complications
Time Frame: 12 months
short-term complications (less than 6 weeks): post-operative pain, urinary retention, denovo urgency and wound sepsis
12 months
Number of participants with long-term complications
Time Frame: 12 months
long-term complications: erosion, dyspareunia and recurrence
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: ahmed reda, M.Sc, AIN shams university

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 10, 2014

Primary Completion (Actual)

June 1, 2017

Study Completion (Actual)

October 1, 2017

Study Registration Dates

First Submitted

August 20, 2014

First Submitted That Met QC Criteria

October 10, 2014

First Posted (Estimate)

October 13, 2014

Study Record Updates

Last Update Posted (Actual)

September 19, 2018

Last Update Submitted That Met QC Criteria

September 18, 2018

Last Verified

September 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress Urinary Incontinence

Clinical Trials on single incision minisling

Subscribe